Paragon Bioservices, Inc.
Yelena Skripchenko is a Scientist at Paragon Bioservices, Inc. where Yelena has been working since September 2013. Prior to this, Yelena held the position of Manager Upstream Production Department at VIRxSYS from August 2004 to December 2012. Yelena also worked as a Scientist III at Genetic Therapy Inc. from 1995 to 2003. Yelena Skripchenko holds a Master's degree in Chemistry, with a specialization in Physical Chemistry, from Novosibirsk State University.
This person is not in any offices
Paragon Bioservices, Inc.
With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.